Market By Products, Applications, End-users And Geography | Forecast 2019-2027
The Asia-Pacific immunohistochemistry market is expected to display an upward trend and is estimated to progress at a CAGR of 7.36% over the forecast period of 2019-2027.
Countries covered in the Asia-Pacific immunohistochemistry market:
• China
• Japan
• India
• South Korea
• ASEAN countries
• Australia & New Zealand
• Rest of Asia-Pacific
To get detailed insights on segments, Download Sample Report
Academic research in China is on the constant rise as it is being well funded and a substantial precision medicine initiative has also been taken up by the Chinese government which is anticipated to provide around $9.2 billion mainly focusing on cancer research providing potential opportunities considering the IVD scenario. The constant rise in the prevalence of cancer in China is acting as a key driver in the growth of the immunochemistry market in the country. The prevalence of lung cancer is the leading cause of cancer deaths in the country. Owing to its surging incidence and mortality, cancer is one of the leading causes of death in China and is a critical public health issue. The highest rate of geriatric population in the country is also impacting the growth of the immunohistochemistry market in the country.
The biotech industry is on the constant rise and is anticipated to experience significant growth considering the favorable business conditions in the country. The upsurging biotech industry in the country is paving the way for the growth of the immunochemistry market in India. The escalating government expenditure is also likely to fuel the growth of the biotechnology industry in India. Moreover, the rising pharmaceutical industry is positively impacting the growth of the biotech industry in the country. In the present scenario, public funding is being offered for research & product innovation considering the biotech sector in the country.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. IMMUNOHISTOCHEMISTRY
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. HISTORY
OF IMMUNOHISTOCHEMISTRY
2.3. VALUE
CHAIN OUTLOOK
2.4. KEY
INSIGHTS
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. MARKET
DRIVERS
2.6.1. IN-VITRO
TECHNOLOGICAL ADVANCEMENTS
2.6.2. INCREASING
CANCER OCCURRENCE
2.6.3. SWELLING
HEALTHCARE SPENDING
2.6.4. INCREASING
USAGE OF POC TESTING
2.7. MARKET
RESTRAINTS
2.7.1. RESTRICTIONS
OF CLOSED SYSTEMS
2.7.2. REIMBURSEMENT
ISSUES
2.8. MARKET
OPPORTUNITIES
2.8.1. INCREASING
USAGE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.8.2. TECHNOLOGICAL
ADVANCEMENTS
2.9. MARKET
CHALLENGES
2.9.1. HIGH
MAINTENANCE COST INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY
ANTIBODIES
3.1.2. SECONDARY
ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE
STAINING SYSTEMS
3.2.2. TISSUE
MICROARRAYS
3.2.3. TISSUE
PROCESSING SYSTEMS
3.2.4. SLIDE
SCANNERS
3.2.5. OTHER
EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL
STAINS
3.3.2. BLOCKING
SERA AND REAGENTS
3.3.3. CHROMOGENIC
SUBSTRATES
3.3.4. FIXATION
REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC
SOLVENTS
3.3.7. PROTEOLYTIC
ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS
DISEASES
4.1.3. CARDIOVASCULAR
DISEASE
4.1.4. AUTOIMMUNE
DISEASES
4.1.5. DIABETES
MELLITUS
4.1.6. NEPHROLOGICAL
DISEASES
4.2. DRUG
TESTING
5. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS
AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH
INSTITUTES
5.3. OTHER
END-USERS
6. IMMUNOHISTOCHEMISTRY
(IHC) REGIONAL OUTLOOK - ASIA-PACIFIC
6.1. COUNTRY
ANALYSIS
6.1.1. CHINA
6.1.2. INDIA
6.1.3. JAPAN
6.1.4. SOUTH
KOREA
6.1.5. AUSTRALIA
& NEW ZEALAND
6.1.6. ASEAN
COUNTRIES
6.1.7. REST
OF APAC
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. ABCAM
PLC
7.3. AGILENT
TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD
LABORATORIES, INC.
7.6. BIO
SB
7.7. CELL
SIGNALING TECHNOLOGY, INC.
7.8. DANAHER
CORPORATION
7.9. F.
HOFFMANN-LA ROCHE AG
7.10.
HISTOLOGIX
7.11.
MERCK MILLIPORE
7.12.
PERKINELMER, INC.
7.13.
SIEMENS AG HEALTHCARE
7.14.
THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY
AND SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1 ASIA-PACIFIC MARKET FOR
IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND
TREATMENT
TABLE 3 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)
TABLE 5 CLINICALLY IMPORTANT MONOCLONAL
ANTIBODIES
TABLE 6 SECONDARY ANTIBODY SELECTION
TABLE 7 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 8 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
IN REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 9 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 10 COMMON FIXATIVES AND THEIR GENERAL TARGET
ANTIGENS
TABLE 11 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
IN KITS 2019-2027 ($ MILLION)
TABLE 12 KIT COMPONENTS ARE AVAILABLE FOR IHC
OPTIMIZATION
TABLE 13 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
BY APPLICATION 2019-2027 ($ MILLION)
TABLE 14 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)
TABLE 15 SELECTED INFECTIOUS ETIOLOGIES OF
AUTOIMMUNE DISEASES
TABLE 16 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
BY END-USERS 2019-2027 ($ MILLION)
TABLE 17 IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC
PATHOLOGY
TABLE 18 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
BY COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 ASIA-PACIFIC MARKET FOR
IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
IN ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 ASIA-PACIFIC ANTIBODIES MARKET IN PRIMARY
ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 5 ASIA-PACIFIC ANTIBODIES MARKET IN
SECONDARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 6 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
IN EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 ASIA-PACIFIC EQUIPMENT MARKET IN SLIDE
STAINING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 8 ASIA-PACIFIC EQUIPMENT MARKET IN TISSUE
MICROARRAYS 2019-2027 ($ MILLION)
FIGURE 9 ASIA-PACIFIC EQUIPMENT MARKET IN TISSUE
PROCESSING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 ASIA-PACIFIC EQUIPMENT MARKET IN SLIDE
SCANNERS 2019-2027 ($ MILLION)
FIGURE 11 ASIA-PACIFIC EQUIPMENT MARKET IN OTHER
EQUIPMENT’S 2019-2027 ($ MILLION)
FIGURE 12 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN
REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 ASIA-PACIFIC REAGENTS MARKET IN HISTOLOGICAL
STAINS 2019-2027 ($ MILLION)
FIGURE 14 ASIA-PACIFIC REAGENTS MARKET IN BLOCKING SERA
AND REAGENTS 2019-2027 ($ MILLION)
FIGURE 15 ASIA-PACIFIC REAGENTS MARKET IN CHROMOGENIC
SUBSTRATES 2019-2027 ($ MILLION)
FIGURE 16 ASIA-PACIFIC REAGENTS MARKET IN FIXATION
REAGENTS 2019-2027 ($ MILLION)
FIGURE 17 ASIA-PACIFIC REAGENTS MARKET IN STABILIZERS
2019-2027 ($ MILLION)
FIGURE 18 ASIA-PACIFIC REAGENTS MARKET IN ORGANIC
SOLVENTS 2019-2027 ($ MILLION)
FIGURE 19 ASIA-PACIFIC REAGENTS MARKET IN PROTEOLYTIC
ENZYMES 2019-2027 ($ MILLION)
FIGURE 20 ASIA-PACIFIC REAGENTS MARKET IN DILUENTS
2019-2027 ($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN
KITS 2019-2027 ($ MILLION)
FIGURE 23 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS
2019-2027 ($ MILLION)
FIGURE 24 ASIA-PACIFIC DIAGNOSTICS MARKET IN CANCER
2019-2027 ($ MILLION)
FIGURE 25 ASIA-PACIFIC DIAGNOSTICS MARKET IN INFECTIOUS
DISEASES 2019-2027 ($ MILLION)
FIGURE 26 ASIA-PACIFIC DIAGNOSTICS MARKET IN
CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)
FIGURE 27 ASIA-PACIFIC DIAGNOSTICS MARKET IN AUTOIMMUNE
DISEASES 2019-2027 ($ MILLION)
FIGURE 28 ASIA-PACIFIC DIAGNOSTICS MARKET IN DIABETES
MELLITUS 2019-2027 ($ MILLION)
FIGURE 29 ASIA-PACIFIC DIAGNOSTICS MARKET IN
NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)
FIGURE 30 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN
DRUG TESTING 2019-2027 ($ MILLION)
FIGURE 31 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN
HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 32 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN
RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 33 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN
OTHER END-USERS 2019-2027 ($ MILLION)
FIGURE 34 ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 35 CHINA IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 36 INDIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 37 JAPAN IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 38 SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 39 AUSTRALIA & NEW ZEALAND
IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 40 ASEAN COUNTRIES IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 41 REST OF APAC IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)